Marshall Wace, LLP Bio N Tech Se Transaction History

Marshall Wace, LLP

$81.7 Billion
Q2 2025

A detailed history of Marshall Wace, LLP transactions in Bio N Tech Se stock. As of the latest transaction made, Marshall Wace, LLP holds 4,842 shares of BNTX stock, worth $501,147. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,842

Previous 255,890 98.11%

Holding current value

$501,147

Previous $23.3 Million 97.79%

% of portfolio

0.0%

Previous 0.03%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$86.65 - $120.54 $21.8 Million - $30.3 Million	-251,048 Reduced 98.11%	4,842 $515,000
Q1 2025 May 15, 2025	BUY	$91.06 - $126.88 $9.63 Million - $13.4 Million	105,733 Added 70.41%	255,890 $23.3 Million
Q4 2024 Feb 13, 2025	BUY	$99.72 - $122.68 $3.71 Million - $4.56 Million	37,177 Added 32.91%	150,157 $17.1 Million
Q3 2024 Nov 14, 2024	BUY	$78.36 - $124.66 $6.03 Million - $9.6 Million	76,995 Added 213.96%	112,980 $13.4 Million
Q2 2024 Aug 14, 2024	BUY	$80.36 - $102.87 $2.89 Million - $3.7 Million	35,985 New	35,985 $2.89 Million
Q4 2022 Feb 14, 2023	BUY	$118.43 - $186.05 $28.2 Million - $44.2 Million	237,709 Added 164.29%	382,397 $57.4 Million
Q3 2022 Nov 14, 2022	SELL	$127.65 - $183.11 $12 Million - $17.2 Million	-93,784 Reduced 39.33%	144,688 $19.6 Million
Q2 2022 Aug 15, 2022	BUY	$123.25 - $186.24 $21.7 Million - $32.7 Million	175,672 Added 279.73%	238,472 $35.6 Million
Q1 2022 May 16, 2022	SELL	$126.25 - $231.85 $13.4 Million - $24.6 Million	-106,207 Reduced 62.84%	62,800 $10.7 Million
Q4 2021 Feb 14, 2022	BUY	$216.64 - $362.52 $36 Million - $60.3 Million	166,367 Added 6301.78%	169,007 $43.3 Million
Q3 2021 Nov 15, 2021	BUY	$205.93 - $447.23 $543,655 - $1.18 Million	2,640 New	2,640 $721,000
Q2 2021 Aug 13, 2021	SELL	$113.32 - $241.49 $3.68 Million - $7.85 Million	-32,499 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$85.73 - $119.5 $1.22 Million - $1.7 Million	14,193 Added 77.53%	32,499 $3.55 Million
Q4 2020 Feb 16, 2021	BUY	$72.71 - $129.54 $1.33 Million - $2.37 Million	18,306 New	18,306 $1.49 Million
Q3 2020 Nov 16, 2020	SELL	$57.81 - $104.17 $255,867 - $461,056	-4,426 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$38.58 - $66.74 $170,755 - $295,391	4,426 New	4,426 $295,000

Others Institutions Holding BNTX

# of Institutions

319

Shares Held

40.9M

Call Options Held

1.38M

Put Options Held

1.52M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $25.1B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Bio N Tech Se Transaction History